Your browser doesn't support javascript.
loading
ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience / 부인종양
Journal of Gynecologic Oncology ; : 6-2020.
Article in English | WPRIM | ID: wpr-782096
ABSTRACT
1.1 g/dL, estimated glomerular filtration rate (eGFR) ≤60 mL/min, ≥3 comorbidities were independently associated with a higher severe toxicity.

CONCLUSIONS:

Elderly patients with EOC can safely be treated with bevacizumab; factors other than age, as higher creatinine serum levels, eGFR and number of comorbidities should be considered to better estimate bevacizumab-related toxicity risk.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ovarian Neoplasms / Case-Control Studies / Comorbidity / Logistic Models / Creatinine / Diagnosis / Drug Therapy / Bevacizumab / Glomerular Filtration Rate Type of study: Diagnostic study / Observational study / Prognostic study / Risk factors Limits: Aged / Female / Humans Language: English Journal: Journal of Gynecologic Oncology Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ovarian Neoplasms / Case-Control Studies / Comorbidity / Logistic Models / Creatinine / Diagnosis / Drug Therapy / Bevacizumab / Glomerular Filtration Rate Type of study: Diagnostic study / Observational study / Prognostic study / Risk factors Limits: Aged / Female / Humans Language: English Journal: Journal of Gynecologic Oncology Year: 2020 Type: Article